Task: Answer the MCQ question.
Query: Which drug exhibits a -1.537% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a: O=C(CSc1nnc(-c2ccccc2)c(-c2ccccc2)n1)NC1CCS(=O)(=O)C1
b: COC(=O)c1ccc(SCC(=O)NC2CCCC2)c([N+](=O)[O-])c1
Answer: b. COC(=O)c1ccc(SCC(=O)NC2CCCC2)c([N+](=O)[O-])c1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COC(=O)c1ccc(SCC(=O)NC2CCCC2)c([N+](=O)[O-])c1
COC(=O)c1ccc(SCC(=O)NC2CCCC2)c([N+](=O)[O-])c1
methyl 4-[2-(cyclopentylamino)-2-oxoethyl]sulfanyl-3-nitrobenzoate